Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

11 Sep, 2021

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions
Photo by Valentin Farkasch on Unsplash

– Neuroglee Therapeutics, a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10m Series A led by Openspace Ventures and EDBI.
– The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston.
– Other participants included Ramen Singh, the former chief executive officer of Mundipharma; Biofourmis co-founders Kuldeep Singh Rajput and Wendou Liu; and Eisai, the Japanese pharmaceutical that led Neuroglee’s last round last year.
– Neuroglee’s adaptive learning tech uses machine learning and biomarkers related to cognitive function, mood and behavior to automatically personalize therapy plans for each patient, who access the software through a smartphone or tablet.

Biotechnology Life Science Southeast Asia
Crunchbase icon

Content report

The following text will be sent to our editors: